on Mar 31,2026
During the Annual Shareholders Meeting of Feldan Therapeutics, held in March 2026, Chairman of the Board Dr. David J. Mazzo addressed the company’s achievements over the past year and outlined …
Read Storyon Mar 12,2026
Quebec City, QC, March 12, 2026 – Feldan Therapeutics (“Feldan”), a clinical-stage biotech company specializing in the development of therapies based on intracellular delivery, today announced, in partnership with TransBIOTech, …
Read Storyon Jan 27,2026
.png)
Quebec City, Canada – January 27, 2026 – Feldan Therapeutics (“Feldan”), a clinical-stage biotech company specializing in the development of therapies based on intracellular delivery, is proud to announce that …
Read Storyon Sep 23,2025
Quebec City, Canada – September 23, 2025 – Feldan Therapeutics (“Feldan”), a clinical-stage biotechnology company specializing in the development of therapies based on intracellular delivery, announces a new collaborative research …
Read Storyon Jun 18,2025
BOSTON, June 16, 2025 – CQDM is proud to announce the funding of two collaborative research projects focused on the development of RNA-based therapies. Unveiled during the BIO International Convention …
Read Storyon Apr 16,2025
Pennington, NJ, USA & Québec, Canada – April 16, 2025 – Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its investment in …
Read Storyon Feb 18,2025
Quebec City, Canada – February 18, 2025 – Feldan Therapeutics ("Feldan"), a clinical-stage pharmaceutical company specialized in the development of treatments based on intracellular delivery of therapeutics, is pleased to …
Read Storyon Jan 22,2025
Quebec City, Canada, January 22, 2025 — Feldan Therapeutics (“Feldan”), a clinical-stage pharmaceutical company specializing in the development of treatments based on intracellular delivery of therapeutics, is pleased to announce …
Read Storyon Oct 31,2024
Quebec City, Canada & Sydney, Australia, October 31 2024 - Feldan Therapeutics (Feldan), a biopharmaceutical company specializing in the development of treatments based on intracellular delivery of therapeutics, has announced …
Read Storyon Sep 4,2024
Quebec City and Toronto, Canada, September 4th, 2024 – Feldan Therapeutics (Feldan), a biopharmaceutical company specializing in the development of treatments based on intracellular delivery of therapeutics, has announced the …
Read Story